We found that expression of constitutively activated Akt2 (MyrAkt2) in immature T lymphocytes can induce T-ALL in mice via chromosome rearrangement-mediated upregulation of Dlx5 or Myc17. The gene discussed is DLX5; the disease is acute lymphoblastic leukemia.